Patients with IPSS-R Intermediate Risk can be Separated Into Three Risk Groups

Authors :: U. Germing
Kathrin Nachtkamp
Stephan Baldus
Barbara Hildebrandt
Martina Rudelius
Andrea Kündgen
T. Reykowski
Rainer Haas
Judith Neukirchen
Corinna Strupp
Tobias Schroeder
Source :: Leukemia Research. 55:S147
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Cancer Research
medicine.medical_specialty
Risk groups
Oncology
business.industry
Urology
medicine
Hematology
business
Intermediate risk

Tools